Penicillin antibiotic with beta-lactamase inhibitor

Amoxicillin / Clavulanic Acid

Clavulin

Dosage form
Tablet
Available strengths
500 mg/125 mg and 875 mg/125 mg tablets; 125 mg/31.25 mg per 5 mL, 200 mg/28.5 mg per 5 mL, 250 mg/62.5 mg per 5 mL, and 400 mg/57 mg per 5 mL oral suspension (amoxicillin / clavulanic acid)
Drug class
Penicillin antibiotic with beta-lactamase inhibitor
Common brand
Clavulin

Clinical overview. Amoxicillin and clavulanic acid, sold as Clavulin, is a penicillin-class antibiotic combined with a beta-lactamase inhibitor used to treat sinus, ear, respiratory, skin, and urinary tract infections caused by susceptible bacteria. It is best taken at the start of a meal to improve absorption and reduce stomach upset. Diarrhea is the most common side effect, while serious allergic reactions, liver problems, and Clostridium difficile-associated diarrhea are important risks to watch for.

Indication

Common therapeutic uses

  • Amoxicillin and clavulanic acid is used to treat sinusitis caused by beta-lactamase-producing bacteria.
  • It is used to treat middle ear infections (otitis media) caused by beta-lactamase-producing bacteria.
  • It is used to treat lower respiratory tract infections caused by susceptible beta-lactamase-producing bacteria.
  • It is used to treat skin and soft tissue infections caused by beta-lactamase-producing Staphylococcus aureus.
  • It is used to treat urinary tract infections caused by beta-lactamase-producing E. coli.

Pregnancy

Risk assessment and monitoring considerations

  • Use during pregnancy should generally be avoided unless considered essential by the treating physician.
  • In one study of women with preterm rupture of membranes, preventive treatment with amoxicillin and clavulanic acid was linked to an increased risk of a serious bowel condition in newborns (necrotizing enterocolitis).

Breastfeeding

Infant exposure considerations

  • Penicillin-type antibiotics, including amoxicillin, pass into human breast milk.
  • It is not known whether clavulanic acid passes into breast milk.
  • Caution should be used when this medicine is given to a breastfeeding mother.

Geriatrics

Dosing and tolerability considerations

  • Older adults may have a higher chance of developing liver-related side effects, particularly with prolonged treatment.

Pediatrics

Use in children and adolescents

  • This medicine can be used in infants 12 weeks of age and older, with dosing based on body weight.
  • In infants younger than 12 weeks, the dose is adjusted because of incompletely developed kidney function that affects how amoxicillin is cleared from the body; the 125 mg/5 mL suspension is recommended for this age group.
  • Twice-daily dosing is preferred over three-times-daily dosing in infants and children because it causes significantly less diarrhea.

Dosage & Administration

Practical dosing and administration

  • For mild to moderate infections in adults, the usual dose is one 500 mg tablet every 12 hours.
  • For more severe infections, including chronic urinary tract infections and lower respiratory infections, the dose is one 875 mg tablet every 12 hours or one 500 mg tablet every 8 hours.
  • In children 12 weeks of age and older, dosing is based on body weight and the amoxicillin component, ranging from 25 mg/kg/day to 45 mg/kg/day divided into two or three doses depending on the infection and its severity.
  • The usual course of treatment is 7 to 10 days, and treatment should continue for at least 48 to 72 hours after symptoms resolve; infections caused by streptococcus require at least 10 days of treatment to prevent complications like rheumatic fever.
  • In adults with reduced kidney function, the dose is reduced to 500 mg/125 mg twice daily for creatinine clearance between 10 and 30 mL/min, and to 500 mg/125 mg once daily for creatinine clearance below 10 mL/min; the 875 mg tablet should only be used if creatinine clearance is above 30 mL/min.
  • Patients on hemodialysis should take one 500 mg/125 mg tablet every 24 hours, plus an extra tablet during dialysis, repeated at the end of dialysis.
  • If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose, in which case the missed dose should be skipped; doses should never be doubled.

Overdose

Recognizing and responding to overdose

If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.

  • Most people who take an overdose have no symptoms, or develop stomach pain, vomiting, and diarrhea.
  • Rash, unusual excitability, or drowsiness have been observed in a small number of overdose cases.
  • Crystals of amoxicillin can form in the kidneys after an overdose, which has led to kidney failure in some cases; maintaining good fluid intake and urine output can reduce this risk.
  • Both amoxicillin and clavulanic acid can be removed from the body by hemodialysis if needed.
  • Activated charcoal may be given to help remove unabsorbed drug, along with general supportive care.

Common side effects

Frequently reported tolerability concerns

  • Diarrhea may occur and is the most commonly reported side effect.
  • Nausea may occur.
  • Vomiting may occur.
  • Yeast infections of the mouth or vagina (candidiasis) may occur.
  • Stomach cramping, gas, or indigestion may occur.
  • Loss of appetite may occur.
  • Headache may occur.
  • Dizziness may occur.
  • Vaginal irritation (vaginitis) may occur.
  • Taking this medicine at the start of a meal can help reduce stomach upset.

Serious side effects

Findings that may require urgent assessment

Serious side effects require immediate discussion with the prescriber or emergency care.

  • Serious, occasionally fatal allergic reactions, including anaphylaxis and severe skin reactions, can occur with this medicine.
  • Severe diarrhea caused by Clostridium difficile infection can occur, sometimes weeks after finishing treatment, and can range from mild to life-threatening.
  • Liver problems, including hepatitis and jaundice, have been reported, more often in men, older adults, and after prolonged treatment; these are usually reversible after stopping the medicine.
  • Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported.
  • Kounis syndrome, a serious allergic reaction that can trigger a heart attack, has been reported.
  • Blood disorders, including anemia, low platelet counts, and low white blood cell counts, have been reported rarely and are usually reversible after stopping the medicine.
  • Interstitial nephritis, a kidney inflammation, can occur rarely.
  • Convulsions may occur, particularly in patients with reduced kidney function or those receiving high doses.
  • Black, hairy discolouration of the tongue, or tooth discolouration in children, has been reported very rarely and is not permanent.
  • Seek urgent medical attention for facial or throat swelling, difficulty breathing, severe or bloody diarrhea, yellowing of the skin or eyes, or a widespread blistering rash.

Use with caution

Situations requiring closer assessment

  • Use with caution in patients with a history of allergies to multiple substances, since they are more likely to have a hypersensitivity reaction.
  • Use with caution in patients with reduced kidney function, since the dose needs to be adjusted.
  • Use with caution in patients with liver disease or a history of liver problems related to this medicine.
  • Use with caution in patients taking oral blood thinners such as warfarin, since this medicine can increase bleeding risk and requires closer monitoring.
  • Use with caution in patients with reduced urine output, since crystal formation in the kidneys is more likely.
  • Use with caution in patients with phenylketonuria when using the oral suspension, since it contains aspartame.
  • Avoid use in patients with infectious mononucleosis, since a rash is more likely to occur.

Contraindications

Situations where therapy may be inappropriate

  • Contraindicated in patients with a known hypersensitivity to penicillins, cephalosporins, or any ingredient in the formulation.
  • Contraindicated in patients with suspected or confirmed infectious mononucleosis.
  • Contraindicated in patients with a previous history of jaundice or liver problems caused by this medicine.

Drug interactions

Clinically relevant combinations

  • This medicine may reduce the effectiveness of combined oral contraceptives; an additional non-hormonal method of birth control is recommended during treatment.
  • Probenecid is not recommended with this medicine, since it increases and prolongs amoxicillin levels in the blood.
  • Combined use with warfarin or acenocoumarol can increase bleeding time and INR, requiring closer monitoring when the antibiotic is started or stopped.
  • This medicine can reduce blood levels of mycophenolic acid in transplant patients taking mycophenolate mofetil.
  • This medicine may reduce the clearance of methotrexate, increasing the risk of methotrexate toxicity.

Food interactions

Meal-related administration

  • Amoxicillin and clavulanic acid can be taken with or without food, but the clavulanic acid component is absorbed better when taken with food.
  • Taking this medicine at the start of a meal is recommended to improve absorption and reduce the chance of stomach upset.

Time of administration

Practical scheduling

  • This medicine is usually taken at the start of a meal to improve absorption of the clavulanic acid component and reduce stomach upset.
  • Doses should be spaced evenly through the day (every 8 or 12 hours, depending on the regimen) to maintain consistent antibiotic levels.

Storage

Product handling

  • Store tablets in a dry place at room temperature (15°C to 25°C).
  • Store unmixed suspension powder in a dry place at room temperature (15°C to 25°C).
  • Once mixed, refrigerate the oral suspension (2°C to 8°C) and discard any unused portion after 7 to 10 days, depending on the formulation.

Patient take-away

Key counselling points for a quick closing summary

  • Take this medicine at the start of a meal to help prevent stomach upset.
  • Finish the entire course of this medicine, even if you feel better, unless your healthcare professional tells you to stop.
  • Tell your healthcare professional if you develop severe or watery diarrhea, even after you finish this medicine.
  • This medicine can make hormonal birth control pills less effective; use a backup method of contraception during treatment.
  • Seek urgent care for facial swelling, difficulty breathing, or a severe skin rash.

References

Source material and product information

  1. Health Canada Product Monograph — Amoxicillin / Clavulanic Acid

For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.